Who to call at MBX Biosciences, Inc., and when
Fundz watches for the moments MBX Biosciences, Inc. starts buying, and tells you who to reach.
- An alert the day MBX Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MBX Biosciences, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MBX Biosciences, Inc.. With Fundz connected, it knows.
MBX Biosciences, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
mbxbio.comAI Executive Summary
AI-powered analysis of 8-K filing content
MBX Biosciences reported Q3 2025 results and disclosed that audit committee chair James M. Cornelius resigned from the Board effective October 31, 2025, and that director Steven Hoerter becomes Executive Chairperson effective November 6, 2025. The changes affect board leadership and audit committee oversight, which investors should monitor.
Key Takeaways
James M. Cornelius resigned from the Board and all committees, including as chairperson of the Audit Committee, effective October 31, 2025, and the filing states the resignation was not due to any dis
Steven Hoerter, a current director, was appointed Executive Chairperson of the Board, effective November 6, 2025, and will work with Mr. Hawryluk in an advisory capacity.
3 more takeaways
Related Filings (11)
11 more filings from MBX Biosciences, Inc. in the last 90 days
Filing Overview
What This Means
MBX Biosciences, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.